← Open Payments lookup

GENUS SARABIA: Open Payments

NPI 1720647944 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$400 in 19 payments from 7 companies in 2025. Trend: 2023 $1,193 · 2024 $1,356 · 2025 $400

Food & beverage: $400
CompanyPaymentsAmount
ViiV Healthcare Company7$141
Merck Sharp & Dohme LLC2$61
ABBVIE INC.3$56
Shionogi Inc2$42
Melinta Therapeutics, LLC2$42
Gilead Sciences, Inc.2$42
Paratek Pharmaceuticals, Inc.1$16

Products named: CABENUVA, Fetroja, AVYCAZ, ZERBAXA, PIFELTRO, Kimyrsa, Yeztugo, DALVANCE.

Industry payments across NV — which companies pay providers there.